IBRX Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in the ImmunityBio, Inc. Class Action SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...

IBRX Stock News: Contact Robbins LLP for Information Regarding ImmunityBio, Inc. Class Action SAN DIEGO, July 18, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...

ImmunityBio, Inc. (IBRX) Investor Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in ImmunityBio, Inc. Class Action SAN DIEGO, July 13, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...

ImmunityBio, Inc. (IBRX) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against ImmunityBio, Inc. SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired...